Latest News
Eaton Stock Rises on UBS Upgrade, $515 Target Hinges on Margin Expansion
UBS upgrades Eaton to Buy with a $515 target, citing strong backlog and margin expansion potential. Shares rise 3% in premarket trading.
ABM's Cash Flow Guidance Upgrade Masks Margin Concern
ABM beat Q3 earnings and raised its cash flow outlook, but shares were flat as margin guidance slipped and 95% of the cash target is already banked.
UNFI Announces $200M Buyback as Profits Recover
UNFI shares rose 3.8% after announcing a $200 million buyback and strong profit recovery, though revenue slightly missed estimates.
Bloom Energy Soars on S&P 500 Inclusion; Valuation at 99x Earnings
Bloom Energy stock surges 5.8% premarket on S&P 500 inclusion, but the stock's 99x forward earnings multiple raises valuation concerns despite strong AI-driven growth.
NAB Stock Dips 1.4% as RBA Rate Hike Dilemma Weighs on Banks
NAB shares fell 1.4% to A$38.87 as Westpac forecast another RBA hike, which could lift deposit earnings but also dampen loan demand and credit quality.
Rubis Guidance Boost Lifts Shares 4%, But Cash Flow Remains Key Test
Rubis shares jumped 4.3% after raising its full-year EBITDA guidance to €775-825M, but a 19% drop in cash flow raises questions about the sustainability of the rally.
Intel's High-NA Milestone: 1M Wafers, But Revenue Gap Looms
Intel's High-NA EUV milestone of 1 million wafers proves technical progress, but external foundry revenue is a mere $293M. The market watches for customer wins.
Rivian's Software Upgrade: A Strategic Move That Doesn't Yet Solve Cash Flow Woes
Rivian's RivianOS 2 update is a strategic step, but RIVN stock still faces an $849 million cash-flow test. The software must cut costs and boost subscriptions, not just improve the interface.
Oil Surges Past $99 After Saudi Attacks; Dow Futures Slide
Brent crude surged past $99 following attacks on Saudi energy facilities, while Dow futures dropped 390 points as investors weigh supply risks and inflation implications.
UiPath Stock Tumbles 16.6% Despite Beat: The ARR Acceleration Challenge
UiPath (PATH) shares dropped 16.6% post-earnings despite a revenue beat, as investors focus on a steep second-half ARR acceleration requirement. The company must add $129.5M in net new ARR, 52% more than H1.
Novartis Shares Plunge 9% as Key Drug Trial Misses Goal
Novartis shares tumbled 9% after its lead Avidity drug failed a pivotal trial, erasing about $22 billion in value and raising doubts about its pipeline.
PG&E's $2B Capex Deferral: A Bid to Cut Debt That Could Cap Growth
PG&E defers $2B in 2027 capex to cut debt, trading at 7.9x forward earnings. The move lowers financial risk but slows growth, as wildfire policy remains unresolved.